Last reviewed · How we verify
Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
The trial studies the efficacy of subcutaneous (SQ) testosterone compared to intramuscular (IM) testosterone therapy during the first 6 months of pubertal induction in transgender male adolescents. Describes rate of adverse effects, masculinizing effects and quality of life while receiving testosterone. Evaluates clinic utilization required for testosterone therapy.
Details
| Lead sponsor | Oregon Health and Science University |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | COMPLETED |
| Enrolment | 26 |
| Start date | Fri Jan 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Health Services for Transgender Persons
- Transgender Persons
Interventions
- Testosterone injection
- PedsQL questionnarie
- Masculinizing effects questionnaire
- Medication experience questionnaire
Countries
United States